ArticleMolecular biotechnology2026
Mechanistic Insights into Effector-Mediated Modulation of Rice Mitochondrial Proteins by Magnaporthe oryzae.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mitochondria are crucial for the plant and animal immunity. The effector protein MoCDIP4 reduces rice immunity by targeting the mitochondria-associated OsDjA9-OsDRP1E protein complex. The present study is focussed on how Magnaporthe oryzae, the fungus that causes rice blast disease, affects mitochondrial dynamics and inhibits innate immune responses in rice plants using molecular modelling, molecular dynamics simulations and free energy-based binding analysis. The protein structure prediction of the effector protein MoCDIP4 and the targets was carried out using artificial intelligence-based tool, AlphaFold. The MD simulation analysis of the effector protein showed significant changes in the secondary structure especially at its C-terminal. The protein-protein complex conformations for OsDjA9-OsDRP1E and OsDjA9-MoCDIP4 were predicted using ab initio molecular methods and energy minimised for enhanced sampling (accelerated) molecular dynamics (MD) simulations. We found that MoCDIP4 targets and binds to the same N-terminal "fork-like" binding site on OsDjA9 which is required for OsDjA9-OsDRP1E complex formation, thereby, resulting in accumulation of OsDRP1E in the mitochondria. Moreover, OsDjA9 was found to undergo large conformational globular folding when bound to OsDRP1E as shown by increased root-mean-square deviation (RMSD) values and overall structural compactness. The binding free energy was calculated by Molecular Mechanics with Generalised Born and Surface Area Solvation (MM/GBSA) model where the OsDjA9-OsDRP1E complexes were scored at - 83.79 kcal/mol and the OsDjA9-MoCDIP4 scored at - 49.24 kcal/mol. The study also highlighted the key residues involved in the interaction of the effector protein as well as from the mitochondria-associated OsDjA9-OsDRP1E protein complex which would pave the path for studying the plant-pathogen interaction.
Indexed as
Identifiers
42469569What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.